FY2025 EPS Estimates for ACRS Decreased by Cantor Fitzgerald
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Stock analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for shares of Aclaris Therapeutics in a report issued on Tuesday, March 18th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company will post earnings of ($0.62) per share for the year, down […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Stock analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for shares of Aclaris Therapeutics in a report issued on Tuesday, March 18th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company will post earnings of ($0.62) per share for the year, down […]
